To Study the EGG Abnormalities in Healthy Subjects and in Patients With Idiopathic and Diabetic Gastroparesis.
NCT ID: NCT05624034
Last Updated: 2022-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2022-11-01
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study aims to study the EGG pattern in healthy individuals in Indian population and the factors associated with it.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intermittent Oro-esophageal Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia
NCT06179550
Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients
NCT01916460
Gastric Pathophysiology in Diabetes
NCT06068114
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
NCT04661215
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
NCT01316484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All the eligible subjects will undergo study procedure i.e. EGG. The study procedure will conduct as per standard study protocol. EGG is a non-invasive, painless method for the measurement of gastric myoelectrical activity. EGG takes around two hours to complete the procedure and no side effects reported. Following steps are included in the procedure
* Subject lie on back on a procedure table.
* Investigator or technician tapes electrodes to Subject's abdomen (belly). The electrodes are similar to those used for other tests, such as an ECG (electrocardiogram). The electrodes measure electrical signals coming from stomach muscles. They send the signals to a computer that records the signals as a graph.
* Investigator or technician records a test while Subject's stomach is empty. An hour later, Subject have something to eat and drink. Investigator or technician then records a second test. The test and electrodes are painless.
* The electrodes are removed. EGG test is completed at this point.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy group
Subjects with no previous medical history (healthy volunteers) will be assessed for eligibility criteria.
Electrogastrography
Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis
Idiopathic Gastroparesis
Patients with symptoms of Gastroparesis based on ROME IV criteria and not having a known cause of gastroparesis like endocrine, neurological, rheumatological disorder.
Electrogastrography
Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis
Diabetic Gastroparesis
Patients with symptoms of Gastroparesis based on ROME IV criteria and Diabetes mellitus of any duration.
Electrogastrography
Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrogastrography
Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy subjects 20 Males and 20 females subjects atleast one will be taken from each group \[18-20,20-30,30-40,40-50,50-60,60-70yrsAbsence of previous upper gastrointestinal surgery anytime in past.
* Absence of drugs which affect the upper gastrointestinal system in 3 months.
* Absence of diabetes,thyroid disorder or neuromuscular disorder.
* Subject who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure
* Subject willing to use appropriate method of contraception as per investigator's discretion, throughout the study
* Idiopathic Gastroparesis
* Male and female subjects above 18 to 70 years of age.
* Subject who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure
* Subject willing to use appropriate method of contraception as per investigator's discretion, throughout the study
* Patient's having symptoms of dyspepsia based on ROME IV Criteria and not having a known cause of gastroparesis like endocrine, neurological, rheumatological disorder.
* ROME IV criteria for Functional Dyspepsia\* (Diagnostic criteria\*\*): One or more of the following
* Bothersome postprandial fullness
* Bothersome early satiation
* Bothersome epigastric pain
* Bothersome epigastric burning AND
* No evidence of structural disease (including at upper endoscopy) that is likely to explain the symptoms
-\*Must fulfill criteria for Postprandial Distress Syndrome (PDS) and/or Epigastric Pain Syndrome (EPS)
-\*\*Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis
* Diabetic Gastroparesis
* Male and female subjects above 18 to 70 years of age.
* Subject who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure
* Subject willing to use appropriate method of contraception as per investigator's discretion, throughout the study
* Patient's having symptoms of dyspepsia based on ROME IV Criteria and Diabetes mellitus of any duration
Exclusion Criteria
* For Idiopathic Gastroparesis
* Subjects suffering from Diabetes
* Subjects with history of any bariatric procedures/ gastric surgeries in the past
* Females who are pregnant
* Subjects taking following medications within 72 hours to the start of the study: Opioids, TCA, Calcium channel blockers, anti-psychotics, anti-cholinergic, steroids, L-Dopa
* Subjects with electrolyte abnormalities like hypokalaemia, hypomagnesemia
* Subjects with known cases of thyroid disorder (hypo or hyperthyroidism)
* Subjects who are unsuitable for any other reason to participate in the study in the opinion of the investigator
* For Diabetic Gastroparesis
* Subjects with history of any bariatric procedures/ gastric surgeries in the past
* Females who are pregnant
* Subjects taking following medications within 72 hours to the start of the study: Opioids, TCA, Calcium channel blockers, anti-psychotics, anti-cholinergic, steroids, L-Dopa
* Subjects with electrolyte abnormalities like hypokalaemia, hypomagnesemia
* Subjects with known cases of thyroid disorder (hypo or hyperthyroidism)
* Subjects who are unsuitable for any other reason to participate in the study in the opinion of the investigator.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asian Institute of Gastroenterology, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rakesh Kalapala
Director Endoscopy[ Center for obesity and metabolic therapy]
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rakesh Kalapala, MBBS,MD,DM
Role: STUDY_DIRECTOR
Senior consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AIG Hospitals
Hyderabad, Telangana, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Riezzo G, Russo F, Indrio F. Electrogastrography in adults and children: the strength, pitfalls, and clinical significance of the cutaneous recording of the gastric electrical activity. Biomed Res Int. 2013;2013:282757. doi: 10.1155/2013/282757. Epub 2013 May 25.
Al Kafee A, Akan A. Analysis of gastric myoelectrical activity from the electrogastrogram signals based on wavelet transform and line length feature. Proc Inst Mech Eng H. 2018 Apr;232(4):403-411. doi: 10.1177/0954411918757812. Epub 2018 Feb 14.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIG/IEC-BH&R32/07.2022-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.